Emerald Advisers’s Merit Medical Systems MMSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-226,514
| Closed | -$20M | – | 255 |
|
|
2025
Q4 | $20M | Sell |
226,514
-54,108
| -19% | -$4.61M | 0.62% | 75 |
|
|
2025
Q3 | $23.4M | Sell |
280,622
-11,168
| -4% | -$973K | 0.75% | 55 |
|
|
2025
Q2 | $27.3M | Buy |
291,790
+11,113
| +4% | +$1.05M | 1% | 35 |
|
|
2025
Q1 | $29.7M | Sell |
280,677
-22,078
| -7% | -$2.28M | 1.34% | 24 |
|
|
2024
Q4 | $29.3M | Sell |
302,755
-12,424
| -4% | -$1.24M | 1.13% | 31 |
|
|
2024
Q3 | $31.1M | Sell |
315,179
-43,974
| -12% | -$4.02M | 1.2% | 28 |
|
|
2024
Q2 | $30.9M | Sell |
359,153
-13,139
| -4% | -$1.03M | 1.29% | 22 |
|
|
2024
Q1 | $28.2M | Buy |
372,292
+681
| +0.2% | +$52.6K | 1.13% | 24 |
|
|
2023
Q4 | $28.2M | Sell |
371,611
-6,324
| -2% | -$441K | 1.21% | 20 |
|
|
2023
Q3 | $26.1M | Buy |
377,935
+2
| +0% | +$144 | 1.26% | 18 |
|
|
2023
Q2 | $31.6M | Sell |
377,933
-2,086
| -0.5% | -$170K | 1.38% | 13 |
|
|
2023
Q1 | $28.1M | Sell |
380,019
-142,151
| -27% | -$9.97M | 1.35% | 18 |
|
|
2022
Q4 | $36.9M | Sell |
522,170
-10,144
| -2% | -$677K | 1.78% | 5 |
|
|
2022
Q3 | $30.1M | Buy |
532,314
+7,106
| +1% | +$409K | 1.55% | 10 |
|
|
2022
Q2 | $28.5M | Sell |
525,208
-33,163
| -6% | -$2.02M | 1.47% | 17 |
|
|
2022
Q1 | $37.1M | Buy |
558,371
+52,020
| +10% | +$3.13M | 1.42% | 17 |
|
|
2021
Q4 | $31.5M | Buy |
506,351
+56,564
| +13% | +$3.79M | 1.16% | 27 |
|
|
2021
Q3 | $32.3M | Buy |
449,787
+80,586
| +22% | +$5.47M | 1.17% | 27 |
|
|
2021
Q2 | $23.9M | Buy |
369,201
+83,840
| +29% | +$5.19M | 0.87% | 40 |
|
|
2021
Q1 | $17.1M | Buy |
285,361
+156,584
| +122% | +$8.97M | 0.62% | 78 |
|
|
2020
Q4 | $7.15M | Buy |
+128,777
| New | +$6.65M | 0.24% | 114 |
|
|
2020
Q3 | – | Sell |
-187,355
| Closed | -$8.55M | – | 349 |
|
|
2020
Q2 | $8.55M | Sell |
187,355
-112,562
| -38% | -$4.54M | 0.37% | 95 |
|
|
2020
Q1 | $9.37M | Sell |
299,917
-102,865
| -26% | -$3.66M | 0.54% | 73 |
|
|
2019
Q4 | $12.6M | Sell |
402,782
-6,470
| -2% | -$185K | 0.53% | 83 |
|
|
2019
Q3 | $12.5M | Buy |
409,252
+155,645
| +61% | +$6.3M | 0.58% | 73 |
|
|
2019
Q2 | $15.1M | Sell |
253,607
-2,690
| -1% | -$154K | 0.61% | 70 |
|
|
2019
Q1 | $15.8M | Sell |
256,297
-66,317
| -21% | -$3.76M | 0.64% | 59 |
|
|
2018
Q4 | $18M | Sell |
322,614
-9,800
| -3% | -$583K | 0.89% | 45 |
|
|
2018
Q3 | $20.4M | Sell |
332,414
-4,830
| -1% | -$277K | 0.75% | 53 |
|
|
2018
Q2 | $17.3M | Buy |
337,244
+34,520
| +11% | +$1.71M | 0.65% | 72 |
|
|
2018
Q1 | $13.7M | Buy |
302,724
+88,833
| +42% | +$4.02M | 0.55% | 79 |
|
|
2017
Q4 | $9.24M | Sell |
213,891
-58,680
| -22% | -$2.46M | 0.36% | 106 |
|
|
2017
Q3 | $11.5M | Buy |
+272,571
| New | +$11M | 0.47% | 82 |
|
Other funds holding MMSI
CCA
NAMI
Emerald Advisers's MMSI Position: Q1 2026 in Review
Emerald Advisers sold out of Merit Medical Systems (MMSI) in Q1 2026, closing a stake of 226,514 shares — an estimated $20M sold.
Emerald Advisers first reported a position in MMSI in Q3 2017 and held it in 33 quarters. The position peaked at $37.1M in Q1 2022. 400 funds tracked by Wall St. Rank hold MMSI as of Q1 2026.
- Emerald Advisers reported no remaining Merit Medical Systems position as of Q1 2026 after selling out during the quarter.
- Emerald Advisers sold 226,514 Merit Medical Systems shares in Q1 2026, an estimated $20M.
- Emerald Advisers first reported a position in Merit Medical Systems in Q3 2017 and held it in 33 quarters.
- Emerald Advisers's Merit Medical Systems position peaked at $37.1M in Q1 2022.
- 400 funds tracked by Wall St. Rank held Merit Medical Systems as of Q1 2026.
Based on Emerald Advisers's 13F filing for Q1 2026, filed 4 May 2026.